Legal pressures and incentives for personalized medicine

Gary Marchant, Robert J. Milligan, Brian Wilhelmi

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which physicians are most at risk of substantial liability.

Original languageEnglish (US)
Pages (from-to)391-397
Number of pages7
JournalPersonalized Medicine
Volume3
Issue number4
DOIs
StatePublished - Nov 2006

Fingerprint

Precision Medicine
Motivation
Pressure
Pharmaceutical Preparations
Health Insurance Reimbursement
Physicians
Legal Liability
Pharmacists
Biomarkers
Therapeutics

Keywords

  • Failure-to-warn
  • Liability
  • Medical malpractice
  • Personalized medicine
  • Pharmacogenomics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Medicine(all)

Cite this

Legal pressures and incentives for personalized medicine. / Marchant, Gary; Milligan, Robert J.; Wilhelmi, Brian.

In: Personalized Medicine, Vol. 3, No. 4, 11.2006, p. 391-397.

Research output: Contribution to journalArticle

Marchant, Gary ; Milligan, Robert J. ; Wilhelmi, Brian. / Legal pressures and incentives for personalized medicine. In: Personalized Medicine. 2006 ; Vol. 3, No. 4. pp. 391-397.
@article{dd84d8d767c946b283dd0a5b32c39990,
title = "Legal pressures and incentives for personalized medicine",
abstract = "Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which physicians are most at risk of substantial liability.",
keywords = "Failure-to-warn, Liability, Medical malpractice, Personalized medicine, Pharmacogenomics",
author = "Gary Marchant and Milligan, {Robert J.} and Brian Wilhelmi",
year = "2006",
month = "11",
doi = "10.2217/17410541.3.4.391",
language = "English (US)",
volume = "3",
pages = "391--397",
journal = "Personalized Medicine",
issn = "1741-0541",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Legal pressures and incentives for personalized medicine

AU - Marchant, Gary

AU - Milligan, Robert J.

AU - Wilhelmi, Brian

PY - 2006/11

Y1 - 2006/11

N2 - Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which physicians are most at risk of substantial liability.

AB - Legal liability has the potential to be a powerful driver pushing implementation of personalized medicine. Individuals injured by adverse drug effects are increasingly likely to bring lawsuits alleging that they have a polymorphism or biomarker conferring susceptibility to the drug that should have been identified and used to alter their drug treatment. Likely targets of such lawsuits include drug manufacturers, third party payors, physicians and pharmacists, of which physicians are most at risk of substantial liability.

KW - Failure-to-warn

KW - Liability

KW - Medical malpractice

KW - Personalized medicine

KW - Pharmacogenomics

UR - http://www.scopus.com/inward/record.url?scp=33845890008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845890008&partnerID=8YFLogxK

U2 - 10.2217/17410541.3.4.391

DO - 10.2217/17410541.3.4.391

M3 - Article

AN - SCOPUS:33845890008

VL - 3

SP - 391

EP - 397

JO - Personalized Medicine

JF - Personalized Medicine

SN - 1741-0541

IS - 4

ER -